18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 5, 2006, Pages 1307-1314

  Yen, Tzu Chen ^a   Lin, Chien Yu ^a   Wang, Hung Ming ^a   Huang, Shiang Fu ^a   Liao, Chun Ta ^a   Kang, Chung Jan ^a   Ng, Shu Hang ^a   Chan, Sheng Chieh ^a   Fan, Kang Hsing ^a   Chen, I How ^a   Lin, Wuu Jyh ^a,b   Cheng, Ann Joy ^a   Chang, Joseph Tung Chieh ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

Author keywords

18F FDG PET; Concurrent chemotherapy and radiation therapy; Nasopharyngeal carcinoma; Response

Indexed keywords

CHEMOTHERAPY; DIAGNOSTIC RADIOGRAPHY; DISEASES; MAGNETIC RESONANCE; PATIENT TREATMENT; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS;

HISTOPATHOLOGICALLY; NASOPHARYNGEAL CARCINOMA; RESIDUAL TUMOR; STANDARD UPTAKE VALUES (SUV);

ONCOLOGY;

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FOLINIC ACID; PENTETIC ACID; UFT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT RESPONSE; EVALUATION; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; NASOPHARYNX TUMOR; NONPARAMETRIC TEST; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; STATISTICS, NONPARAMETRIC;

EID: 33748519870     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.02.031     Document Type: Article

References (39)

1. Huang D.P. Epidemiology and aetiology. In: Hasselt C.A.V., and Gibb A.G. (Eds). Nasopharyngeal carcinoma (1991), The Chinese University Press, Hong Kong 23-44
2. Easton J.M., Levine P.H., and Hyams V.J. Nasopharyngeal carcinoma in the United States. A pathological study of 177 US and 30 foreign cases. Arch Otolaryngol 106 (1980) 88-91
3. Choo R., and Tannock I. Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret Hospital experience. Cancer 68 (1991) 2120-2124
4. Gebbia V., Zerillo G., Restivo G., et al. Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma. A retrospective analysis of 40 cases. Br J Cancer 68 (1993) 191-194
5. Chang J.T., See L.C., Liao C.T., et al. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol 54 (2000) 135-142
6. Chang K.P., Hao S.P., Tsang N.M., and Ueng S.H. Salvage surgery for locally recurrent nasopharyngeal carcinoma. A 10-year experience. Otolaryngol Head Neck Surg 131 (2004) 497-502
7. Chang J.T., Chen L.H., Tang S.G., et al. Acute toxicities and feasibility of altered fractionated radiotherapy in nasopharyngeal carcinoma. Chang Gung Med J 20 (1997) 107-114
8. Le Q.T., Tate D., Koong A., et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 56 (2003) 1046-1054
9. Lee A.W.M., Law S.C.K., Foo W., et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985. Survival after local recurrence. Int J Radiat Oncol Biol Phys 26 (1993) 773-782
10. Vikram B., and Hilaris B. Transnasal permanent interstitial implantation for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 10 (1984) 153-155
11. Choy D., Sham J.S., Wei W.I., Ho C.M., and Wu F.M. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 25 (1993) 505-512
12. Park J.O., Lee S.I., Song S.Y., et al. Measuring response in solid tumors. Comparison of RECIST and WHO response criteria. Jap J Clin Oncol 33 (2003) 533-537
13. Prasad S.R., Saini S., Sumner J.E., Hahn P.F., Sahani D., and Boland G.W. Radiological measurement of breast cancer metastases to lung and liver. Comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines. J Comput Assist Tomogr 27 (2003) 380-384
14. Chong V.F.H., and Fan Y.F. Detection of recurrent nasopharyngeal carcinoma. MR imaging versus CT. Radiology 202 (1997) 463-470
15. Olmi P., Fallai C., Colagradne S., and Giannardi G. Staging and follow up of nasopharyngeal carcinoma. Magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys 32 (1995) 795-800
16. Gong Q.Y., Zheng G.L., and Zhu H.Y. MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis. Comput Med Imaging Graph 15 (1991) 423-429
17. Ng S.H., Chang T.C., Ko S.F., Wan Y.L., Tang L.M., and Chen W.C. MRI in recurrent nasopharyngeal carcinoma. Neuroradiology 41 (1999) 855-862
18. Ng S.H., Wan Y.L., Ko S.F., and Chang J.T. MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy. J Magn Reson Imaging 8 (1998) 327-336
19. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 44 (2003) 224-239
20. 18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix. Response and outcome. J Clin Oncol 22 (2004) 2167-2171
21. Swisher S.G., Erasmus J., Maish M., et al. 2-fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101 (2004) 1776-1785
22. Vansteenkiste J., Fischer B.M., Dooms C., and Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer. Systemic review. Lancet Oncol 5 (2004) 531-540
23. Ng S.H., Chang J.C.T., Chan S.C., et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 45 (2004) 1669-1676
24. Lin J.C., Jan J.S., Hsu C.Y., Liang W.M., Jiang R.S., and Wang W.Y. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma. Positive effect on overall and progression-free survival. J Clin Oncol 21 (2003) 631-637
25. Hicks R.J., Mac Manus M.P., Matthews J.P., et al. Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer. Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. Int J Radiat Oncol Biol Phys 60 (2004) 412-418
26. Fleming I.D., Cooper J.S., Henson D.E., et al. AJCC Cancer staging manual. 6th ed. (2002), Lippincott Williams & Wilkins, Philadelphia 35
27. Yen T.C., Ng K.K., Ma S.Y., et al. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. J Clin Oncol 21 (2003) 3651-3658
28. Minn H., Joensuu H., Ahonen A., and Klemi P. Fluorodeoxyglucose imaging. A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 61 (1988) 1766-1781
29. Guillem J.G., Moore H.G., Akhurst T., et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation. A means for determining longterm outcomes of rectal cancer. J Am Coll Surg 199 (2004) 1-7
30. Kitagawa Y., Sadato N., Azuna H., et al. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med 40 (1999) 1132-1137
31. Kitagawa Y., Sano K., Nishizawa S., et al. FDG-PET for prediction of tumor aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30 (2003) 63-71
32. Halfpenny W., Hain S.F., Biassoni L., et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 86 (2002) 512-516
33. Allal A.S., Dulguerov P., Allaoua M., et al. Standardized uptake value of 2-[18F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20 (2002) 1398-1404
34. Swisher S.G., Erasmus J., Maish M., et al. 2-fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101 (2004) 1776-1785
35. Yao M., Graham M.M., Hoffman H.T., et al. The role of post-radiation therapy FDG PET in prediction of necessity for postradiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 1001-1010
36. Kitagawa Y., Nishizawa S., Sano K., et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44 (2003) 198-206
37. Brucher B.L., Weber W., Bauer M., et al. Neoadjuvant therapy of esophageal squamous cell carcinoma. Response evaluation by positron emission tomography. Ann Surg 233 (2001) 300-309
38. Rege S.D., Chaiken L., Hoh C.K., et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of head and neck. Quantitation with PET. Radiology 198 (1993) 807-812
39. Chaiken L., Rege S., Hoh C., et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 27 (1993) 455-464